Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001104659-20-081211

Options or other derivatives

  • Chief Financial Officer acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Dahms Bradford D. · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-07-01 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +40,000 $2.84 2030-06-30 40,000 40,000 D
Loading xslF345X03/a4.xml…